Ausgabe 5/2005
Inhalt (18 Artikel)
Good News and Bad News: Now the Bad News
Antihypertensive drugs and incidence of type 2 diabetes: Evidence and implications for clinical practice
Samuel Asfaha, Raj Padwal
Management of hypertension in overweight and obese patients: A practical guide for clinicians
Francesco Dentali, Arya M. Sharma, James D. Douketis
The role of aldosterone antagonists in the management of resistant hypertension
Mari K. Nishizaka, David A. Calhoun
Hypertension in pregnancy
Maryann Mugo, Gurushankar Govindarajan, L. Romayne Kurukulasuriya, James R. Sowers, Samy I. McFarlane
Combination Drug Treatment for Hypertension
Should the target for blood pressure control specify both a systolic and a diastolic component?
Christopher J. Hebert, Ganesh Shidham, Lee A. Hebert
The African American Study of Kidney Disease: Do these results indicate that 140/90 mm Hg is good enough?
Mahboob Rahman, Ashraf El-Meanawy, Joseph Romanello
Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention
Kenneth L. Choi, William J. Elliott
Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?
Stephan J. L. Bakker, Ron T. Gansevoort, Erik M. Stuveling, Rijk O. B. Gans, Dick de Zeeuw
Does dietary salt increase the risk for progression of kidney disease?
Shiraz I. Mishra, Charlotte Jones-Burton, Jeffrey C. Fink, Jeanine Brown, George L. Bakris, Matthew R. Weir